Pazenir - direct healthcare professional communication (DHPC)

paclitaxel
DHPCHuman

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Περί

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Έγγραφα

Pazenir® (paclitaxel formulated as albumin bound nanoparticles) 5 mg/ml powder for dispersion for infusion: temporary supply shortage

English (EN) (112.7 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Key facts

Medicine name
Pazenir
Active substance
paclitaxel
Therapeutic area (MeSH)
Breast Neoplasms
Procedure number
EMEA/H/C/004441
DHPC type
Medicine shortage
Human ATC codes
L01CD01
Dissemination date

Share this page